COEP Company Profile and Key Details
Coeptis Therapeutics, Inc.
COEP Stock Price Chart
Stock Price Today
Coeptis Therapeutics, Inc. (COEP) stock surged +13.56%, trading at $10.80 on PNK, up from the previous close of $9.51. The stock opened at $9.87, fluctuating between $9.73 and $10.80 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Coeptis Therapeutics, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the ability to pre-determine which cancer patients are most likely to benefit from targeted anti-CD38 monoclonal antibodies therapies. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Company Information
| Employees | 5 |
| Beta | -0.94 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Coeptis Therapeutics, Inc. (PNK: COEP) stock price is $10.80 in the last trading session. During the trading session, COEP stock reached the peak price of $10.80 while $9.73 was the lowest point it dropped to. The percentage change in COEP stock occurred in the recent session was 13.56% while the dollar amount for the price change in COEP stock was $1.29.
The PNK listed COEP is part of Biotechnology industry that operates in the broader Healthcare sector. Coeptis Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Gary R. Conte
Senior Vice President of Sales & Marketing
Mr. Daniel Alexander Yerace
Co-Founder, Vice President of Operations & Director
Mr. Brian Cogley M.B.A.
Chief Financial Officer
Ms. Christine Elise Sheehy
Senior Vice President of Global Integration
Mr. David Mehalick
Co-Founder, Chairman, Chief Executive Officer & Pres
COEP's closing price is 33.91% higher than its 52-week low of $2.31 where as its distance from 52-week high of $13.58 is -83.35%.
Number of COEP employees currently stands at 5.
Official Website of COEP is: https://coeptispharma.com
COEP could be contacted at phone 724 934 6467 and can also be accessed through its website. COEP operates from 105 Bradford Road, Wexford, PA 15090, United States.
COEP stock volume for the day was 57.98K shares. The average number of COEP shares traded daily for last 3 months was 358.92K.
The market value of COEP currently stands at $25.97M with its latest stock price at $10.80 and 2.4M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com